Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 1,300 | 0 | 100 | 0 |
| Gross Profit | N/A | 1,300 | N/A | 100 | N/A |
| Operating Expenses | 33,812 | 28,689 | 42,901 | 50,028 | 46,797 |
| Operating Income | -33,812 | -27,389 | -42,901 | -49,928 | -46,797 |
| Interest Expense | 3,181 | 3,141 | 2,689 | 0 | 0 |
| Other Income | 1,737 | 1,878 | 2,279 | 2,063 | 2,933 |
| Pre-tax Income | -35,256 | -28,652 | -43,311 | -47,865 | -43,864 |
| Income Tax | N/A | 2 | N/A | N/A | N/A |
| Net Income Continuous | -35,256 | -28,654 | -43,311 | -47,865 | -43,864 |
| Net Income | $-35,256 | $-28,654 | $-43,311 | $-47,865 | $-43,864 |
| EPS Basic Total Ops | -2.28 | -1.85 | -2.80 | -4.48 | -2.84 |
| EPS Basic Continuous Ops | -2.28 | -1.85 | -2.80 | -4.48 | -2.84 |
| EPS Diluted Total Ops | -2.28 | -1.85 | -2.80 | -4.25 | -2.84 |
| EPS Diluted Continuous Ops | -2.28 | -1.85 | -2.80 | -4.25 | -2.84 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.85 | -2.80 | -3.09 | -2.84 |
| EBITDA(a) | $-33,229 | $-26,728 | $-42,226 | $-49,239 | $-46,037 |